Quest Diagnostics Incorporated (NYSE: DGX) is expected to release earnings results for its fourth quarter, before the opening bell on Feb. 1, 2024.
Analysts expect the company to report quarterly earnings at $2.11 per share, up from year-ago earnings of $1.98 per share. The company is projected to report revenue of $2.25 billion, compared to $2.33 billion in the year-earlier quarter, according to data from Benzinga Pro.
Fitbit and Quest Diagnostics announced a collaboration to advance research on the use of wearable devices to improve metabolic health.
Quest Diagnostics shares fell 0.3% to close at $128.43 on Wednesday.
Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can ...